Search Results - S. Mark Tompkins
- Showing 1 - 14 results of 14
-
1
-
2
Fitness Determinants of Influenza A Viruses by Emily Fate Griffin, Stephen Mark Tompkins
Published in Viruses (2023-09-01)Get full text
Article -
3
-
4
-
5
Development and characterization of an immortalized swine respiratory cell line for influenza A virus research by Peter J. Neasham, Peter J. Neasham, Vasilis C. Pliasas, Vasilis C. Pliasas, J. Fletcher North, J. Fletcher North, Celeste Johnson, S. Mark Tompkins, S. Mark Tompkins, Constantinos S. Kyriakis, Constantinos S. Kyriakis, Constantinos S. Kyriakis
Published in Frontiers in Veterinary Science (2023-12-01)Get full text
Article -
6
Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection. by Zhuo Li, Jon D Gabbard, Scott Johnson, Daniel Dlugolenski, Shannon Phan, S Mark Tompkins, Biao He
Published in PLoS ONE (2015-01-01)Get full text
Article -
7
Swine influenza A virus isolates containing the pandemic H1N1 origin matrix gene elicit greater disease in the murine model by Shelly J. Curran, Emily F. Griffin, Lucas M. Ferreri, Constantinos S. Kyriakis, Elizabeth W. Howerth, Daniel R. Perez, S. Mark Tompkins
Published in Microbiology Spectrum (2024-03-01)Get full text
Article -
8
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model by Vasilis C. Pliasas, Vasilis C. Pliasas, Peter J. Neasham, Peter J. Neasham, Maria C. Naskou, Rachel Neto, Philip G. Strate, J. Fletcher North, J. Fletcher North, Stephen Pedroza, Strickland D. Chastain, Ian Padykula, Ian Padykula, S. Mark Tompkins, S. Mark Tompkins, Constantinos S. Kyriakis, Constantinos S. Kyriakis, Constantinos S. Kyriakis
Published in Frontiers in Immunology (2023-10-01)Get full text
Article -
9
Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1 by Stephen Mark Tompkins, Zi-Shan Zhao, Chia-Yun Lo, Julia A. Misplon, Teresa Liu, Zhiping Ye, Robert J. Hogan, Zhengqi Wu, Kimberly A. Benton, Terrence M. Tumpey, Suzanne L. Epstein
Published in Emerging Infectious Diseases (2007-03-01)Get full text
Article -
10
Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models by Ian Padykula, Lambodhar Damodaran, Kelsey T. Young, Madelyn Krunkosky, Emily F. Griffin, James F. North, Peter J. Neasham, Vasilis C. Pliasas, Chris L. Siepker, James B. Stanton, Elizabeth W. Howerth, Justin Bahl, Constantinos S. Kyriakis, Stephen Mark Tompkins
Published in Viruses (2024-03-01)Get full text
Article -
11
Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns by Anice C. Lowen, Amy L. Baker, Andrew S. Bowman, Adolfo García-Sastre, Scott E. Hensley, Seema S. Lakdawala, Louise H. Moncla, Martha I. Nelson, Andrew Pekosz, Rebecca L. Poulson, Wendy B. Puryear, Jonathan A. Runstadler, Troy C. Sutton, S. Mark Tompkins, Richard J. Webby
Published in Journal of Virology (2025-04-01)Get full text
Article -
12
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates by Ashley C. Beavis, Peng Xiao, Maria Cristina Gingerich, Kelsey Briggs, Geng Li, Elizabeth W. Howerth, Maria Najera, Dong An, Jiachen Huang, Jarrod Mousa, S. Mark Tompkins, Gina Kim, Stephen B. Harvey, Robert Jeffrey Hogan, Eric R. Lafontaine, Francois J. Villinger, Hong Jin, Biao He
Published in Journal of Virology (2025-04-01)Get full text
Article -
13
Ferrets as a model for tuberculosis transmission by Tuhina Gupta, Naveen Somanna, Thomas Rowe, Thomas Rowe, Monica LaGatta, Shelly Helms, Simon Odera Owino, Tomislav Jelesijevic, Stephen Harvey, Wayne Jacobs, Thomas Voss, Kaori Sakamoto, Cheryl Day, Christopher Whalen, Russell Karls, Biao He, S. Mark Tompkins, Abhijeet Bakre, Ted Ross, Frederick D. Quinn
Published in Frontiers in Cellular and Infection Microbiology (2022-08-01)Get full text
Article -
14
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants by Ashley C. Beavis, Zhuo Li, Kelsey Briggs, María Cristina Gingerich, Elizabeth R. Wrobel, Maria Najera, Dong An, Nichole Orr-Burks, Jackelyn Murray, Preetish Patil, Jiachen Huang, Jarrod Mousa, Linhui Hao, Tien-Ying Hsiang, Michael Gale, Stephen B. Harvey, S. Mark Tompkins, Robert Jeffrey Hogan, Eric R. Lafontaine, Hong Jin, Biao He
Published in Journal of Virology (2025-04-01)Get full text
Article
